Connection

WOLFGANG WINKELMAYER to Administration, Oral

This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Administration, Oral.
Connection Strength

0.504
  1. Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020 09; 29(5):489-496.
    View in: PubMed
    Score: 0.153
  2. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation. Am J Kidney Dis. 2015 Oct; 66(4):677-88.
    View in: PubMed
    Score: 0.107
  3. Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks? Curr Opin Nephrol Hypertens. 2012 Nov; 21(6):600-6.
    View in: PubMed
    Score: 0.089
  4. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):57-65.
    View in: PubMed
    Score: 0.077
  5. Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. N Engl J Med. 2021 04 29; 384(17):1589-1600.
    View in: PubMed
    Score: 0.040
  6. Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics. Am Heart J. 2021 05; 235:1-11.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.